22-50076841-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_015166.4(MLC1):​c.597A>G​(p.Ser199Ser) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.128 in 1,612,712 control chromosomes in the GnomAD database, including 13,883 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.12 ( 1076 hom., cov: 33)
Exomes 𝑓: 0.13 ( 12807 hom. )

Consequence

MLC1
NM_015166.4 splice_region, synonymous

Scores

2
Splicing: ADA: 0.00005492
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -1.43

Publications

14 publications found
Variant links:
Genes affected
MLC1 (HGNC:17082): (modulator of VRAC current 1) The function of this gene product is unknown; however, homology to other proteins suggests that it may be an integral membrane transporter. Mutations in this gene have been associated with megalencephalic leukoencephalopathy with subcortical cysts, an autosomal recessive neurological disorder. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
MLC1 Gene-Disease associations (from GenCC):
  • megalencephalic leukoencephalopathy with subcortical cysts 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Myriad Women’s Health
  • megalencephalic leukoencephalopathy with subcortical cysts
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 22-50076841-T-C is Benign according to our data. Variant chr22-50076841-T-C is described in ClinVar as Benign. ClinVar VariationId is 129615.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.43 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.214 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015166.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MLC1
NM_015166.4
MANE Select
c.597A>Gp.Ser199Ser
splice_region synonymous
Exon 7 of 12NP_055981.1
MLC1
NM_001376472.1
c.597A>Gp.Ser199Ser
splice_region synonymous
Exon 6 of 11NP_001363401.1
MLC1
NM_001376473.1
c.597A>Gp.Ser199Ser
splice_region synonymous
Exon 8 of 13NP_001363402.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MLC1
ENST00000311597.10
TSL:1 MANE Select
c.597A>Gp.Ser199Ser
splice_region synonymous
Exon 7 of 12ENSP00000310375.6
MLC1
ENST00000395876.6
TSL:1
c.597A>Gp.Ser199Ser
splice_region synonymous
Exon 7 of 12ENSP00000379216.2
MLC1
ENST00000442311.1
TSL:5
c.507A>Gp.Ser169Ser
splice_region synonymous
Exon 6 of 8ENSP00000401385.1

Frequencies

GnomAD3 genomes
AF:
0.116
AC:
17630
AN:
152046
Hom.:
1072
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.103
Gnomad AMI
AF:
0.110
Gnomad AMR
AF:
0.157
Gnomad ASJ
AF:
0.0597
Gnomad EAS
AF:
0.0889
Gnomad SAS
AF:
0.225
Gnomad FIN
AF:
0.0725
Gnomad MID
AF:
0.115
Gnomad NFE
AF:
0.118
Gnomad OTH
AF:
0.131
GnomAD2 exomes
AF:
0.125
AC:
31277
AN:
251120
AF XY:
0.131
show subpopulations
Gnomad AFR exome
AF:
0.103
Gnomad AMR exome
AF:
0.123
Gnomad ASJ exome
AF:
0.0669
Gnomad EAS exome
AF:
0.0879
Gnomad FIN exome
AF:
0.0801
Gnomad NFE exome
AF:
0.121
Gnomad OTH exome
AF:
0.127
GnomAD4 exome
AF:
0.129
AC:
188041
AN:
1460548
Hom.:
12807
Cov.:
32
AF XY:
0.132
AC XY:
95766
AN XY:
726692
show subpopulations
African (AFR)
AF:
0.102
AC:
3428
AN:
33454
American (AMR)
AF:
0.130
AC:
5800
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.0639
AC:
1669
AN:
26128
East Asian (EAS)
AF:
0.0990
AC:
3929
AN:
39686
South Asian (SAS)
AF:
0.222
AC:
19178
AN:
86218
European-Finnish (FIN)
AF:
0.0843
AC:
4495
AN:
53352
Middle Eastern (MID)
AF:
0.139
AC:
802
AN:
5758
European-Non Finnish (NFE)
AF:
0.127
AC:
141098
AN:
1110896
Other (OTH)
AF:
0.127
AC:
7642
AN:
60342
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.451
Heterozygous variant carriers
0
8993
17987
26980
35974
44967
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5230
10460
15690
20920
26150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.116
AC:
17647
AN:
152164
Hom.:
1076
Cov.:
33
AF XY:
0.116
AC XY:
8646
AN XY:
74412
show subpopulations
African (AFR)
AF:
0.104
AC:
4308
AN:
41520
American (AMR)
AF:
0.157
AC:
2394
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0597
AC:
207
AN:
3468
East Asian (EAS)
AF:
0.0891
AC:
461
AN:
5174
South Asian (SAS)
AF:
0.225
AC:
1087
AN:
4822
European-Finnish (FIN)
AF:
0.0725
AC:
768
AN:
10600
Middle Eastern (MID)
AF:
0.106
AC:
31
AN:
292
European-Non Finnish (NFE)
AF:
0.118
AC:
8018
AN:
67980
Other (OTH)
AF:
0.129
AC:
273
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
821
1642
2464
3285
4106
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
202
404
606
808
1010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.119
Hom.:
2680
Bravo
AF:
0.119
Asia WGS
AF:
0.147
AC:
510
AN:
3478
EpiCase
AF:
0.117
EpiControl
AF:
0.123

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:2
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed.

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Megalencephalic leukoencephalopathy with subcortical cysts 1 Benign:2
Jun 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Megalencephalic leukoencephalopathy with subcortical cysts Benign:1
Dec 09, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
0.024
DANN
Benign
0.36
PhyloP100
-1.4
Mutation Taster
=50/50
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000055
dbscSNV1_RF
Benign
0.010
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6010164; hg19: chr22-50515270; COSMIC: COSV61118238; COSMIC: COSV61118238; API